Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Sales (2018 - 2025)

Historic Return on Sales for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to 0.29%.

  • Dna X's Return on Sales fell 1300.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year decrease of 3500.0%. This contributed to the annual value of 0.59% for FY2024, which is 5900.0% down from last year.
  • As of Q3 2025, Dna X's Return on Sales stood at 0.29%, which was down 1300.0% from 0.67% recorded in Q2 2025.
  • Dna X's Return on Sales' 5-year high stood at 0.03% during Q1 2025, with a 5-year trough of 1.49% in Q4 2024.
  • Moreover, its 5-year median value for Return on Sales was 0.29% (2025), whereas its average is 0.38%.
  • In the last 5 years, Dna X's Return on Sales soared by 6900bps in 2022 and then plummeted by -14200bps in 2024.
  • Quarter analysis of 5 years shows Dna X's Return on Sales stood at 0.74% in 2021, then surged by 93bps to 0.05% in 2022, then plummeted by -41bps to 0.07% in 2023, then tumbled by -2050bps to 1.49% in 2024, then surged by 80bps to 0.29% in 2025.
  • Its Return on Sales stands at 0.29% for Q3 2025, versus 0.67% for Q2 2025 and 0.03% for Q1 2025.